| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/S41440-018-0034-4 |
| P698 | PubMed publication ID | 29556093 |
| P2093 | author name string | Mitsuru Ohishi | |
| P2860 | cites work | Morning hypertension in chronic kidney disease is sustained type, but not surge type | Q83178141 |
| Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure | Q28080114 | ||
| Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass | Q28360314 | ||
| Sympathetic Nervous System, Hypertension, Obesity and Metabolic Syndrome | Q30251839 | ||
| Molecular mechanisms of diabetic vascular complications | Q33558421 | ||
| Mechanisms linking angiotensin II and atherogenesis | Q34916067 | ||
| Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points | Q35689563 | ||
| Mechanism of the blood pressure-lowering effect of sodium-glucose cotransporter 2 inhibitors in obese patients with type 2 diabetes | Q36341246 | ||
| Renal effects | Q36402873 | ||
| Metabolic syndrome and type 2 diabetes: can we stop the weight gain with diabetes? | Q36983388 | ||
| Oxidative Stress in Diabetic Nephropathy | Q37003803 | ||
| Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without type 2 diabetes | Q37435002 | ||
| Clinical application of incretin-based therapy: therapeutic potential, patient selection and clinical use. | Q37493196 | ||
| Small artery remodeling in diabetes mellitus | Q37501134 | ||
| Increased cardiovascular risk of treated white coat and masked hypertension in patients with diabetes and chronic kidney disease: the HONEST Study. | Q37575333 | ||
| Pathology of human diabetic nephropathy | Q37887374 | ||
| Pathogenesis and progression of proteinuria | Q37887376 | ||
| Clinical importance of assessment of type 2 diabetes mellitus with visceral obesity. A Japanese perspective | Q37981759 | ||
| Microinflammation in the pathogenesis of diabetic nephropathy | Q38213048 | ||
| Receptor for advanced glycation endproducts and progressive kidney disease | Q38282233 | ||
| Management of diabetic nephropathy: Recent progress and future perspective | Q38407220 | ||
| Insulin Signaling in the Control of Glucose and Lipid Homeostasis | Q38684496 | ||
| Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: An update. | Q38939250 | ||
| Review: The renin-angiotensin-aldosterone system, blockade and diabetic nephropathy | Q39092015 | ||
| Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment | Q39112475 | ||
| The pathogenic role of the kidney | Q40110529 | ||
| Association between changes in systolic blood pressure and incident diabetes in a community-based cohort study in Korea. | Q40312414 | ||
| The insulin-like growth factor system in vascular smooth muscle: interaction with insulin and growth factors | Q40369440 | ||
| Epidemiology of high blood pressure and obesity. | Q40387899 | ||
| beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis | Q45105931 | ||
| Regulation of the Na+/K+-ATPase by insulin: why and how? | Q48021636 | ||
| Insulin as a vascular hormone: implications for the pathophysiology of cardiovascular disease. | Q54138227 | ||
| Nifedipine controlled-release 40 mg b.i.d. in Japanese patients with essential hypertension who responded insufficiently to nifedipine controlled-release 40 mg q.d.: a phase III, randomized, double-blind and parallel-group study | Q58362780 | ||
| Sodium restriction shifts circadian rhythm of blood pressure from nondipper to dipper in essential hypertension | Q73762733 | ||
| Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population: the Hisayama study | Q80382261 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 389-393 | |
| P577 | publication date | 2018-03-19 | |
| P1433 | published in | Hypertension Research | Q15762136 |
| P1476 | title | Hypertension with diabetes mellitus: physiology and pathology | |
| P478 | volume | 41 |
| Q90966888 | An interesting cross-talk between the glucagon-like peptide-1 receptor axis and angiotensin receptor pathway for modulation of renal sodium handling in obesity |
| Q55014613 | Association of Blood Pressure with Fasting Blood Glucose Levels in Northeast China: A Cross-Sectional Study. |
| Q90571480 | Association of Insulin Resistance, Plasma Glucose Level, and Serum Insulin Level With Hypertension in a Population With Different Stages of Impaired Glucose Metabolism |
| Q89746051 | Effect of diabetes mellitus on short-term prognosis of 227 pyogenic liver abscess patients after hospitalization |
| Q61455036 | Epidemiology of Self-Reported Diabetes Mellitus in the State of Maranhão, Northeastern Brazil: Results of the National Health Survey, 2013 |
| Q90289369 | Evaluation of Blood Pressure Control and Associated Factors among Patients with Hypertension in Iraq: A Prospective Cross-sectional Study |
| Q89518891 | Low blood pressure and cardiovascular events in diabetic patients with coronary artery disease after revascularization: the CREDO-Kyoto registry cohort-1 |
| Q91142614 | Metformin prevents vascular damage in hypertension through the AMPK/ER stress pathway |
| Q92643999 | Predictors of isolated systolic hypertension among type 2 diabetes mellitus patients in Jimma University Specialized Hospital, Southwest Ethiopia |
| Q58693859 | Proarrhythmic Remodeling of Calcium Homeostasis in Cardiac Disease; Implications for Diabetes and Obesity |
| Q90344421 | Provoking factors for postpartum chronic hypertension in women with preceding gestational hypertension/preeclampsia: A longitudinal cohort study of 22,798 pregnancies |
| Q60925235 | The Effects of Systemic and Local Acidosis on Insulin Resistance and Signaling |
Search more.